New Zealand markets closed

Greenfern Industries Limited (GFI.NZ)

NZSE - NZSE Delayed price. Currency in NZD
Add to watchlist
0.03900.0000 (0.00%)
At close: 04:29PM NZST

Greenfern Industries Limited

General Capital House
Level 8 115 Queen Street
Auckland 1140
New Zealand
64 9 304 0145
https://gfi.nz

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Daniel CaseyMD & Exec. Director176.2kN/AN/A
Mr. Hao LongChief Financial OfficerN/AN/AN/A
- MatthewOperations Mang.N/AN/AN/A
Mr. Jeremy Mills-HoulihanHead of CultivationN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in NZD.

Description

Greenfern Industries Limited operates as an entrepreneurial led licensed medicinal cannabis research and biotechnology company in New Zealand. It operates in the medicinal cannabis, industrial hemp, hemp food, and body care spaces. The company was incorporated in 2018 and is headquartered in Auckland, New Zealand.

Corporate governance

Greenfern Industries Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.